HERC1 and acute myeloid leukemia: These results indicated that in AML patients the HERC1 gene expression level was significantly lower at diagnosis and not associated with any of the different cytogenetic/genetic group with the interesting exception of the five AML patients harboring the IDH2 R140Q mutation which displayed HERC1 levels indistinguishable from the control group.